Atlas Trials

Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.

Clinical trial NCT04931537 · RECRUITING

Trial details

NCT number
NCT04931537
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Study type
OBSERVATIONAL
Diabetic Nephropathy Type 2Biomarker
Start date
2021-05-01
Primary completion
2023-12-31
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.